메인페이지 비즈니스포럼 사업/연구발표회

사업/연구발표회
 
 
 
 
HALL E1
Presentation
Time
Company's
Logo
Country
Company's Name
Presentation Title
13:00~13:30 Shine BioPharma
Republic of Korea
-ShineBiopharma for the Success to New Drug Development Thru Novel Platforms
13:30~14:00 SCM Lifescience
Republic of Korea
SCM Lifescience’s Technologies and Preclinical and Clinical Outcomes with Clonal MSCs
14:00~14:30 Boehringer Ingelheim
Germany
Working together for better health: Partnering with Boehringer Ingelheim
14:30~15:00 Eurocine Vaccines AB
Sweden
Immunose™ FLU, a nasal influenza vaccine candidate formulated as nose drops
15:00~15:30 Optimede Corp
Republic of Korea
Superbug Infection Free Single Use Disposable Endoscope
15:30~16:00 SAMSUNG MEDICAL CENTER
Republic of Korea
Big Data Driven Precision Medicine in Institute for Refractory Cancer Research
16:00~16:30 Laviana Pharma Co., Ltd
China
Laviana-Your Chemistry Outsourcing Partner from Development to Manufacture
16:30~17:00 EPS International
Singapore
EPS International: Asia's role in generating a Roadmap from Korea to Global.
 
HALL E2
Presentation
Time
Company's
Logo
Country
Company's Name
Presentation Title
13:00~13:30 DHL Consulting
Singapore
Strategic Logistics Consulting for Bio Industry
13:30~14:00 KBI Biopharma Inc.
United States of America
Accelerated CMC Approaches for Therapeutic Antibody Development and Manufacturing
14:00~14:30 Break
Australian Clinical Trials Capability Seminar
14:30~14:40 Australia
AusBiotech
Welcome speech
14:40~15:00 Australia
MTPConnect
Keynote speaker 1:
A Dynamic Environment for conducting Clinical Trials
15:00~15:20 Australia
Novotech
Keynote speaker 2:
Australia in the global multi-centre clinical trials environment
15:20~15:40 Australia
Cosec Consulting
Keynote speaker 3:
Australia's R&D Tax Incentive ? benefits to sponsors ? a case study
15:45~16:30



Australia
CMAX Clinical Research
George Clinical
Linear Clinical Research
Nucleus Network
Q-Pharm
Panel discussion
Chair :
-Sue MacLeman, CEO MTP Connect Panelist:
-Jane Kelly, CEO, CMAX Clinical Research
-Evon Hui, Associate Director, George Clinical
-Dougal Thring, Partner Solutions Lead, Linear Clinical Research
-Cameron Johnson, CEO, Nucleus Network
-Bradley Joblin, Chief Scientific Officer, Q-Pharm